A000640 Stock Overview
Engages in the pharmaceutical business in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Dong-A Socio Holdings Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩124,300.00 |
| 52 Week High | ₩128,500.00 |
| 52 Week Low | ₩88,800.00 |
| Beta | 0.21 |
| 11 Month Change | 4.89% |
| 3 Month Change | 14.46% |
| 1 Year Change | 31.40% |
| 33 Year Change | 14.04% |
| 5 Year Change | 46.75% |
| Change since IPO | 290.73% |
Recent News & Updates
Recent updates
Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Business Is Trailing The Market But Its Shares Aren't
Aug 13
Key Things To Watch Out For If You Are After Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) 0.8% Dividend
Apr 29These 4 Measures Indicate That Dong-A Socio Holdings (KRX:000640) Is Using Debt Extensively
Apr 08Are Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Mixed Financials Driving The Negative Sentiment?
Mar 18What Type Of Shareholders Own The Most Number of Dong-A Socio Holdings Co., Ltd. (KRX:000640) Shares?
Feb 25A Look At Dong-A Socio Holdings' (KRX:000640) Share Price Returns
Feb 04
Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?
Jan 14Is It Smart To Buy Dong-A Socio Holdings Co., Ltd. (KRX:000640) Before It Goes Ex-Dividend?
Dec 24Dong-A Socio Holdings (KRX:000640) Takes On Some Risk With Its Use Of Debt
Dec 13Dong-A Socio Holdings Co., Ltd.'s (KRX:000640) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Nov 22Shareholder Returns
| A000640 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 6.3% | 0.7% | -0.5% |
| 1Y | 31.4% | 40.7% | 7.3% |
Return vs Industry: A000640 underperformed the KR Pharmaceuticals industry which returned 38.8% over the past year.
Return vs Market: A000640 exceeded the KR Market which returned 6.3% over the past year.
Price Volatility
| A000640 volatility | |
|---|---|
| A000640 Average Weekly Movement | 4.5% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in KR Market | 12.2% |
| 10% least volatile stocks in KR Market | 3.6% |
Stable Share Price: A000640 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A000640's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | 5,530 | Jae-Hun Jung | www.donga.co.kr |
Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally. It develops DA-1241 for the treatment of type 2 diabetes and non-alcoholic steatohepatitis; DA-1726, an oxyntomodulin analogue to treat obesity; DA-1229, a dipeptidyl peptidase-4 inhibitor class treatment for type 2 diabetes; DA-8010, a muscarinic M3 receptor antagonist for the treatment of overactive bladder; DMB-3115, a biosimilar of Stelara and an inflammatory disease treatment; DA-3880 to treat anemia; STP0404, an HIV-1 treatment drug; and STP1002, an anti-cancer drug. The company also provides healthcare solutions to customers in Bacchus, over-the-counter, consumer healthcare, and derma business areas; CDMO services; imaging equipment and ENT workstation products; mineral water under the Cheonnyeonsu brand name; and IT and construction services.
Dong-A Socio Holdings Co., Ltd. Fundamentals Summary
| A000640 fundamental statistics | |
|---|---|
| Market cap | ₩776.96b |
| Earnings (TTM) | ₩51.02b |
| Revenue (TTM) | ₩1.22t |
15.2x
P/E Ratio0.6x
P/S RatioIs A000640 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A000640 income statement (TTM) | |
|---|---|
| Revenue | ₩1.22t |
| Cost of Revenue | ₩825.89b |
| Gross Profit | ₩395.09b |
| Other Expenses | ₩344.07b |
| Earnings | ₩51.02b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.16k |
| Gross Margin | 32.36% |
| Net Profit Margin | 4.18% |
| Debt/Equity Ratio | 59.7% |
How did A000640 perform over the long term?
See historical performance and comparison